341 related articles for article (PubMed ID: 19436275)
1. H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole.
Yang HB; Sheu BS; Wang ST; Cheng HC; Chang WL; Chen WY
Am J Gastroenterol; 2009 Jul; 104(7):1642-9. PubMed ID: 19436275
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up.
Kim N; Park RY; Cho SI; Lim SH; Lee KH; Lee W; Kang HM; Lee HS; Jung HC; Song IS
J Clin Gastroenterol; 2008; 42(5):448-54. PubMed ID: 18344895
[TBL] [Abstract][Full Text] [Related]
3. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.
Zhou L; Sung JJ; Lin S; Jin Z; Ding S; Huang X; Xia Z; Guo H; Liu J; Chao W
Chin Med J (Engl); 2003 Jan; 116(1):11-4. PubMed ID: 12667379
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis: Prospective endoscopic evaluation.
Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K; Okada H; Yamamoto K
J Gastroenterol Hepatol; 2009 Jan; 24(1):107-13. PubMed ID: 18823429
[TBL] [Abstract][Full Text] [Related]
5. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.
Toyokawa T; Suwaki K; Miyake Y; Nakatsu M; Ando M
J Gastroenterol Hepatol; 2010 Mar; 25(3):544-7. PubMed ID: 19817964
[TBL] [Abstract][Full Text] [Related]
6. Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients.
Tulassay Z; Stolte M; Sjölund M; Engstrand L; Butruk E; Malfertheiner P; Dite P; Tchernev K; Wong BC; Gottlow M; Eklund S; Wrangstadh M; Nagy P
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):526-36. PubMed ID: 18467912
[TBL] [Abstract][Full Text] [Related]
7. Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients.
Massarrat S; Haj-Sheykholeslami A; Mohamadkhani A; Zendehdel N; Rakhshani N; Stolte M; Mirzaei M; Saliminejhad M; Saeidi S; Shahidi M
Arch Iran Med; 2012 Nov; 15(11):664-9. PubMed ID: 23102241
[TBL] [Abstract][Full Text] [Related]
8. Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group.
Voutilainen M; Färkkilä M; Mecklin JP; Juhola M; Sipponen P
Am J Gastroenterol; 1999 Nov; 94(11):3175-80. PubMed ID: 10566710
[TBL] [Abstract][Full Text] [Related]
9. Short-term celecoxib to regress long-term persistent gastric intestinal metaplasia after Helicobacter pylori eradication.
Hung KH; Yang HB; Cheng HC; Wu JJ; Sheu BS
J Gastroenterol Hepatol; 2010 Jan; 25(1):48-53. PubMed ID: 19793174
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation.
Kodama M; Murakami K; Okimoto T; Abe T; Nakagawa Y; Mizukami K; Uchida M; Inoue K; Fujioka T
Digestion; 2012; 85(2):126-30. PubMed ID: 22269293
[TBL] [Abstract][Full Text] [Related]
11. Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer.
Cho SJ; Choi IJ; Kook MC; Yoon H; Park S; Kim CG; Lee JY; Lee JH; Ryu KW; Kim YW
Aliment Pharmacol Ther; 2013 Sep; 38(5):477-89. PubMed ID: 23822578
[TBL] [Abstract][Full Text] [Related]
12. Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms.
Nam SY; Choi IJ; Ryu KH; Kim BC; Kim CG; Nam BH
Am J Gastroenterol; 2010 Oct; 105(10):2153-62. PubMed ID: 20571493
[TBL] [Abstract][Full Text] [Related]
13. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease?
Fallone CA; Barkun AN; Friedman G; Mayrand S; Loo V; Beech R; Best L; Joseph L
Am J Gastroenterol; 2000 Apr; 95(4):914-20. PubMed ID: 10763937
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori eradication and antral intestinal metaplasia--two years follow-up study.
Ciok J; Dzieniszewski J; Lucer C
J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():115-22. PubMed ID: 9440062
[TBL] [Abstract][Full Text] [Related]
16. Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients.
Sheu BS; Yang HB; Sheu SM; Huang AH; Wu JJ
Clin Cancer Res; 2003 Nov; 9(14):5245-51. PubMed ID: 14614005
[TBL] [Abstract][Full Text] [Related]
17. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.
Watari J; Das KK; Amenta PS; Tanabe H; Tanaka A; Geng X; Lin JJ; Kohgo Y; Das KM
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):409-17. PubMed ID: 18321787
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: a three-year follow-up study in Korea.
Kang JM; Kim N; Shin CM; Lee HS; Lee DH; Jung HC; Song IS
Helicobacter; 2012 Apr; 17(2):86-95. PubMed ID: 22404438
[TBL] [Abstract][Full Text] [Related]
19. Intestinal metaplasia of the gastric cardia.
Morales TG; Sampliner RE; Bhattacharyya A
Am J Gastroenterol; 1997 Mar; 92(3):414-8. PubMed ID: 9068460
[TBL] [Abstract][Full Text] [Related]
20. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
